FDA Informed Consent Guidance Under Development; HIV Studies Present Unique Challenges

When early “cure” research is unlikely to lead to study participants’ own HIV cure, the informed consent hurdle is high, patients told FDA. But will new guidance offer sufficient help and a successful path forward?